Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
Background: Long acting injectable (LAI) antipsychotics have been claimed to ensure treatment adherence and possibly reduce the daily burden of oral formulations. So far, only surveys investigating the theoretical prescribing attitudes of clinicians have been employed. On this basis, we aimed to inv...
Main Authors: | Corrado Barbui, Federico Bertolini, Francesco Bartoli, Carmela Calandra, Camilla Callegari, Giuseppe Carrà, Armando D’Agostino, Claudio Lucii, Giovanni Martinotti, Daniele Mastromo, Daniele Moretti, Emiliano Monzani, Matteo Porcellana, Davide Prestia, Giovanni Ostuzzi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/2045125320978102 |
Similar Items
-
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
by: Corrado Barbui, et al.
Published: (2016-01-01) -
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.
by: Giovanni Ostuzzi, et al.
Published: (2018-01-01) -
Are depot as effective as oral antipsychotics on first-episode psychosis?
by: Cristián Orus, et al.
Published: (2016-06-01) -
Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
by: Barbui Corrado, et al.
Published: (2011-09-01) -
Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
by: Ranković Anica, et al.
Published: (2018-03-01)